Neuromodulation has evolved beyond existing as a ''one-size-fits-all'' therapy. Innovation is now aimed at creating indication-specific therapies that play to the strengths of each breakthrough. This session will attempt to elucidate which therapies are better suited for certain indications based on the current evidence available.
Upon completion of this educational activity, participants should be able to:
- Review evidence for each therapy and what pathologies are supported by the evidence.
- Explain the basic science of each therapy to highlight the fundamental differences between them.
- Identify the best practices for each therapy.
- Discuss the evidence and data for therapy by indications or parts of the body.
Peripheral Nerve Stimulation: Indications and Evidence
Michael A. Fishman, MD MBA
10,000 Hz: Indications and Evidence
Jessica Jameson, MD
Dorsal Root Ganglion Stimulation: Indications and Evidence
Corey W. Hunter, MD FIPP
Burst Stimulation: Indications and Evidence
Kiran V. Patel, MD
The Choice Between Targeted Drug Delivery vs. Spinal Cord Stimulation for Chronic Pain: Science or Conventional Wisdom?
Nagy A. Mekhail, MD
Faculty and Presentations subject to change.
- Open- vs. Closed-Loop Neurostimulation and Enabling Biomarkers
- American Academy of Pain Medicine (AAPM) Session: Integrating Neuromodulation Into Multimodal Pain Care
- Beyond Depression: Use of TMS for the Treatment of Pain, Tinnitus, and Other Neuropsychiatric Illnesses
- Plenary Session III
- Placing Leads Elsewhere: Peripheral Nerve Stimulation